Sionna Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2024 | $-52.8M | $-52.8M | $27.0K | $3.7M |
| FY2025 | $-66.3M | $-66.7M | $377.0K | $12.1M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2024 | $-52.8M | $-52.8M | $27.0K | $3.7M |
| FY2025 | $-66.3M | $-66.7M | $377.0K | $12.1M |